[EN] CYTOTOXIC SUBSTITUTED 2-(1 H-PYRAZOL-1 -YL)-1,3-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF CANCER<br/>[FR] COMPOSÉS 2-(1H-PYRAZOL-1-YL)-1,3-BENZOTHIAZOLE SUBSTITUÉS CYTOTOXIQUES POUR LE TRAITEMENT DU CANCER
申请人:BAYER PHARMA AG
公开号:WO2016202759A1
公开(公告)日:2016-12-22
The present invention relates to substituted 2-(1lH-pyrazol-1-yl)-1,3-benzothiazole compounds of general formula (I) : in which R1, R2, R3, R4, R5, R6 and R7 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.
本发明涉及通式(I)所示的取代的2-(1H-吡唑-1-基)-1,3-苯并噻唑化合物,其中R1、R2、R3、R4、R5、R6和R7如本文所定义,以及制备该化合物的方法,用于制备该化合物的有用中间体化合物,包括该化合物的药物组合物和组合物,以及用于制造药物组合物以治疗或预防疾病,特别是肿瘤的用途,作为唯一药剂或与其他活性成分组合使用。